Alkermes plc. License Agreements
10 Contracts & Agreements
- Agreement Amendment No. 2, dated as of July 31, 2009, to the License Agreement by and among Elan Pharmaceutical Research Corp., d/b/a Nanosystems and Elan Pharma International... (Filed With SEC on April 26, 2023)
- License Agreement by and among Elan Pharmaceutical Research Corp., d/b/a Nanosystems and Elan Pharma International Limited and Janssen Pharmaceutica N.V. dated as of March 31, 1999 (Filed With SEC on April 26, 2023)
- Third Amendment to Development and License Agreement, dated March 20, 2018, by and between Amylin Pharmaceuticals, LLC and Alkermes Pharma Ireland Limited (as... (Filed With SEC on April 26, 2018)
- LICENSE AGREEMENT (Filed With SEC on February 25, 2016)
- LICENSE AGREEMENT (Filed With SEC on February 25, 2016)
- LICENSE AGREEMENT (Filed With SEC on July 30, 2015)
- LICENSE AGREEMENT (Filed With SEC on July 30, 2015)
- LICENSE AGREEMENT by and among ELAN PHARMACEUTICAL RESEARCH CORP., d/b/a NANOSYSTEMS and ELAN PHARMA INTERNATIONAL LIMITED and JANSSEN PHARMACEUTICA N.V. March 31, 1999 This... (Filed With SEC on May 23, 2013)
- ELAN PHARMA INTERNATIONAL LIMITED AND ACORDA THERAPEUTICS, INC. DEVELOPMENT AND SUPPLEMENTAL AGREEMENT TO AMENDED AND RESTATED LICENSE AGREEMENT DATED 26 SEPTEMBER 2003 AS AMENDED... (Filed With SEC on May 23, 2013)
- SECOND AMENDMENT TO LICENSE AGREEMENTS FIFTH AMENDMENT TO MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on November 1, 2012)
